share_log

Is Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Latest Stock Performance A Reflection Of Its Financial Health?

Is Intuitive Surgical, Inc.'s (NASDAQ:ISRG) Latest Stock Performance A Reflection Of Its Financial Health?

Intuitive Surgical公司(纳斯达克股票代码:ISRG)的最新股票表现是否代表其财务健康状况?
Simply Wall St ·  07/26 09:19

Intuitive Surgical's (NASDAQ:ISRG) stock is up by a considerable 16% over the past three months. Since the market usually pay for a company's long-term fundamentals, we decided to study the company's key performance indicators to see if they could be influencing the market. Particularly, we will be paying attention to Intuitive Surgical's ROE today.

过去三个月,直觉外科公司(纳斯达克代码:ISRG)的股价飙升了16%。由于市场通常会为一家公司的长期基本面买单,我们决定研究公司的关键业绩指标,看看它们是否可能影响市场。特别是今天我们将关注一下直觉外科公司的roe。

Return on equity or ROE is a key measure used to assess how efficiently a company's management is utilizing the company's capital. In simpler terms, it measures the profitability of a company in relation to shareholder's equity.

股东权益回报率(roe)是一种关键指标,用于评估公司管理层如何有效利用公司资本。更简单地说,它衡量了公司相对股东权益的盈利能力。

How Do You Calculate Return On Equity?

怎样计算ROE?

Return on equity can be calculated by using the formula:

股东权益报酬率可以使用以下公式计算:

Return on Equity = Net Profit (from continuing operations) ÷ Shareholders' Equity

净资产收益率 = 净利润(从持续经营中获得)÷ 股东权益

So, based on the above formula, the ROE for Intuitive Surgical is:

因此,根据以上公式,直觉外科公司的ROE为:

14% = US$2.1b ÷ US$15b (Based on the trailing twelve months to June 2024).

14%= 21亿美元/ 1,500亿美元(基于截至2024年6月的过去12个月)

The 'return' is the profit over the last twelve months. One way to conceptualize this is that for each $1 of shareholders' capital it has, the company made $0.14 in profit.

“回报”是过去十二个月的盈利。一个概念是,对于它拥有的每1美元股东资本,该公司获得了0.14美元的利润。

What Has ROE Got To Do With Earnings Growth?

ROE与盈利增长有什么关系?

Thus far, we have learned that ROE measures how efficiently a company is generating its profits. Depending on how much of these profits the company reinvests or "retains", and how effectively it does so, we are then able to assess a company's earnings growth potential. Generally speaking, other things being equal, firms with a high return on equity and profit retention, have a higher growth rate than firms that don't share these attributes.

到目前为止,我们学到了ROE如何评估公司有效地产生利润。根据公司再投资或“保留”的这些利润的多少以及其如何有效地进行再投资,我们可以评估公司的盈利增长潜力。一般而言,在其他条件相同的情况下,ROE高、利润保留高的公司,比没有这些属性的公司增长率更高。

A Side By Side comparison of Intuitive Surgical's Earnings Growth And 14% ROE

直觉外科公司盈利增长与14%的ROE并列比较

To begin with, Intuitive Surgical seems to have a respectable ROE. Further, the company's ROE compares quite favorably to the industry average of 11%. This certainly adds some context to Intuitive Surgical's decent 8.3% net income growth seen over the past five years.

首先,直觉外科公司似乎具有可观的ROE。此外,公司的ROE与行业平均水平相比非常有优势,行业平均水平为11%。这无疑为直觉外科公司过去五年中相当不错的8.3%净收入增长增加了一些背景。

Next, on comparing Intuitive Surgical's net income growth with the industry, we found that the company's reported growth is similar to the industry average growth rate of 8.7% over the last few years.

接下来,我们将直觉外科公司的净收入增长与行业进行对比,发现该公司报告的增长与过去几年中行业平均增长率8.7%相似。

big
NasdaqGS:ISRG Past Earnings Growth July 26th 2024
纳斯达克GS:ISRG过去的盈利增长2024年7月26日

Earnings growth is an important metric to consider when valuing a stock. It's important for an investor to know whether the market has priced in the company's expected earnings growth (or decline). This then helps them determine if the stock is placed for a bright or bleak future. Is Intuitive Surgical fairly valued compared to other companies? These 3 valuation measures might help you decide.

盈利增长是估值股票时必须考虑的重要指标。对于投资者来说,了解市场是否已经定价了公司预期的盈利增长(或下降)非常重要。这有助于他们判断股票是面临光明前景还是黯淡前景。与其他公司相比,直觉外科公司的公平价值定价如何?这3个估值指标可能会为您做决定。

Is Intuitive Surgical Using Its Retained Earnings Effectively?

直觉外科公司是否有效利用其留存收益?

Given that Intuitive Surgical doesn't pay any regular dividends to its shareholders, we infer that the company has been reinvesting all of its profits to grow its business.

因为直觉外科公司不向股东支付常规股息,所以我们推断该公司一直在重新投资其所有利润以增长业务。

Conclusion

结论

On the whole, we feel that Intuitive Surgical's performance has been quite good. Particularly, we like that the company is reinvesting heavily into its business, and at a high rate of return. Unsurprisingly, this has led to an impressive earnings growth. That being so, the latest analyst forecasts show that the company will continue to see an expansion in its earnings. To know more about the latest analysts predictions for the company, check out this visualization of analyst forecasts for the company.

总体而言,我们认为直觉外科公司的表现相当不错。特别是,我们喜欢公司大量重新投资业务并以高回报率获得利润的做法。毫不奇怪,最新的分析师预测显示该公司的盈利将继续扩张。要了解更多关于该公司最新分析师预测的信息,请查看本可视化分析师预测公司的内容。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。
这篇文章是Simply Wall St的一般性文章。我们根据历史数据和分析师预测提供评论,只使用公正的方法论,我们的文章并不意味着提供任何金融建议。文章不构成买卖任何股票的建议,也不考虑您的目标或您的财务状况。我们的目标是带给您基本数据驱动的长期关注分析。请注意,我们的分析可能不考虑最新的价格敏感公司公告或定性材料。Simply Wall St没有任何股票头寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

对本文有任何反馈?对内容有任何疑虑?请直接与我们联系。或者,发送电子邮件至editorial-team@simplywallst.com。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发